CLINUVEL’s Head of Clinical Operations, Dr Pilar Bilbao, discusses the recent results from the CUV151 study, looking at whether afamelanotide can reduce and repair photodamage (skin damage induced by ultraviolet radiation) in healthy volunteers.
Stay up to date on our DNA Repair Program: https://www.clinuvel.com/disease-entities/dna-repair/
Read the technical note accompanying the CUV151 announcement:
https://www.clinuvel.com/technical-note-dna-damage-20230815/
In case you missed it, watch CLINUVEL’s Genomic Expert Dr Jessica Nucci discuss the science behind the CUV156 results: https://youtu.be/Hz1SyWyJnyI